Johnson & Johnson CEO On The Company’s Transformation

Published by
ValueWalk

Following is the unofficial transcript of a CNBC interview with Johnson & Johnson (NYSE:JNJ) CEO Joaquin Duato and CNBC’s Senior Health & Science Reporter Meg Tirrell live during CNBC’s “Healthy Returns Summit: Reality, Recovery and Opportunity” today, Wednesday, March 30. CNBC’s Interview With Johnson & Johnson CEO Joaquin Duato____ MEG TIRRELL: I want to bring in now our first guest Joaquin Duato, the CEO of Johnson & Johnson. J&J of course was instrumental in the vaccine race for COVID-19. We’re going to talk about that but Joaquin first I just want to welcome you. You know first time we’ve…

Read More

See also  Antidepressants Market to Gain Traction; Takeda and Lundbeck Receive Approval from Japan’s Healthy Ministry for Trintellix, Their Depression Treatment

Leave a Reply